Alnylam Pharmaceuticals, Inc.

NasdaqGS:ALNY

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

💊 Pharmaceuticals

Location

United States

Market Cap

USD 57.53 B

Share Price

USD 438.93

Avg Daily Volume

1,009,291

Change (1 day)

0.88%

Change (1 year)

62.29%

Change (YTD)

86.53%

Alnylam Pharmaceuticals, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending June 30, 2025: USD -15.54 M

Alnylam Pharmaceuticals, Inc. Operating Cash Flow is USD -15.54 M for the Trailing 12 Months (TTM) ending June 30, 2025, a -104.17% change year over year. Operating cash flow is cash generated from the company’s regular business operations.

Alnylam Pharmaceuticals, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending June 30, 2024 was USD 372.26 M, a -178.75% change year over year.
Alnylam Pharmaceuticals, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending June 30, 2023 was USD -472.72 M, a -18.24% change year over year.
Alnylam Pharmaceuticals, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending June 30, 2022 was USD -578.19 M, a -2.17% change year over year.
Alnylam Pharmaceuticals, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending June 30, 2021 was USD -590.99 M, a -22.25% change year over year.